We would like to share with our clients and colleagues this important letter regarding the priority given to clinical trials in Israel by the MoH.
We are always here to assist you in your clinical trial. Feel free to reach out!

Share this article
Blog
Navigating Importation Regulations for Clinical Trials

Importing Investigational Medicinal Products (IMPs) and medical supplies for clinical trials is a complex and highly regulated process. Unlike standard commercial imports, clinical trial importation involves unique regulatory and logistical challenges that require specialized expertise. At IMP, we ensure a seamless and compliant importation process, working closely with regulatory authorities, customs officials, and shipping providers […]

Blog
Navigating Regulatory Differences: The Role of Qualified Persons in Israel and the EU

In the global landscape of clinical trials, regulatory frameworks vary significantly from one region to another. One of the most critical aspects of these frameworks is the role of the Qualified Person (QP), a function that is mandatory in the European Union but differs considerably in other regions, such as Israel. Understanding these differences is […]

Blog
Navigating the Clinical Supply Chain for Clinical Trials in the EU

At IMP Clinical Supply Services Ltd., we are privileged to oversee a crucial aspect of the clinical trial process: the clinical supply chain. The European market presents a unique set of challenges and opportunities for bio-startups, particularly in the realm of clinical trials. Understanding and navigating these complexities is essential for any company looking to […]

Contact Us

    Back to top